Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03556293 · ClinicalTrials.gov registry record · NA
IMPROVE AKI Cluster-Randomized Trial
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10,252
- Enrollment target
NCT03556293: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT03556293 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10,252 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (631% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03556293, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,252 participants
- Enrollment target
Study Summary
When a person has an imaging procedure that uses radio-contrast dye, there is a possibility of damage to that person's kidneys, which could result in being on dialysis or early death. The investigators are testing novel coaching and automated tools to help healthcare teams apply approaches that have been shown to prevent damage to kidneys during a cardiac catheterization procedure. The results of our study will help inform health care leaders on how to implement low-cost preventive strategies through team-based coaching and surveillance reporting for kidney injury and other patient safety priorities to every hospital in the United States.
Primary Outcome
Number of Participants with Acute Kidney Injury
Interventions
- BEHAVIORAL AKI Prevention Toolkit
- BEHAVIORAL Technical Assistance (TA)
- BEHAVIORAL Virtual Learning Collaborative (VLC)
- BEHAVIORAL Automated Surveillance Reporting (ASR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,252 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
What the finished NCT03556293 record still lists
NCT03556293 is an interventional study that assigns participants to a tested intervention. Its 10,252 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (631% higher).
The record links to 0 conditions, and to 4 interventions - of which AKI Prevention Toolkit is the first listed.
NCT03556293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03556293 about?
NCT03556293 is a clinical study titled "IMPROVE AKI Cluster-Randomized Trial". When a person has an imaging procedure that uses radio-contrast dye, there is a possibility of damage to that person's kidneys, which could result in being on dialysis or early death. The investigators are testing novel coaching and automated tools to help healthcare teams apply approaches that have...
What is the current status of trial NCT03556293?
This trial is currently completed. It is a NA study. The enrollment target is 10,252 participants. The study started on 2019-09-01. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT03556293?
The interventions under investigation include: AKI Prevention Toolkit (BEHAVIORAL), Technical Assistance (TA) (BEHAVIORAL), Virtual Learning Collaborative (VLC) (BEHAVIORAL), Automated Surveillance Reporting (ASR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03556293?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03556293's enrollment target sits among peer trials
10,252 14th of 2000 higher than 1,987 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04332783 · 10,120 participants · NA
Isolating and Mitigating Sequentially Dependent Perceptual Errors in Clinical Visual Search
- NCT07157774 · 10,450 participants · Phase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- NCT05759299 · 10,500 participants
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
- NCT06891222 · 10,500 participants
A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI